IN THE NEWS
San Diego Union Tribune
July 28, 2026His father suffered from gout in silence. Now a San Diego scientist is bringing the cure home
Power to the Patients
July 23, 2026The Gout Narrative Keeping Patients Sick and What Crystalys Therapeutics Is Doing Differently
The Pharma Letter
July 23, 2026Crystalys banks $130m to push gout drug dotinurad toward US and EU launch
Clinical Trials Arena
July 23, 2026Crystalys banks $130m to progress gout drug, plan for commercial readiness
The Wall Street Journal
July 23, 2026Biotech Startup Gets $130 Million to Settle ‘Unfinished Business’
Biopharma Dive
July 22, 2026Crystalys nets $130M more to push gout drug through late-stage tests
The startup has a broad global development program underway — and widespread investor support — for a treatment that’s approved in many Asian countries but isn’t yet available in the U.S. or Europe. read more →
Genetic Engineering & Biotechnology News
June 1, 2026Attacking Gout: Crystalys Sees Room for Its Dotinurad and Other Allopurinol Alternatives
Clinical Leader
April 3, 2026With A Clear Focus And Promising Asset, Crystalys Is Skipping Phase 2 Trials For Gout
Endpoints News
January 23, 2026Former FDA deputies land at Lilly, AbbVie; Italy’s Angelini has a new CEO
Progress Potential and Possibilities
January 23, 2026Dr. James Mackay, Ph.D. – CEO, Crystalys Therapeutics – Next Generation Treatments For Gout
The San Diego Union-Tribune
November 27, 2025Funding for San Diego startups tumbles to smallest quarterly investment total in 8 years
Pharmaceutical Technology
October 23, 2025Biotechs brush off sector headwinds in venture financing rebound
Clinical Trials Arena
October 22, 2025Crystalys Therapeutics begins Phase III trials for gout treatment
MedCity News
September 30, 2025Startup Crystalys Therapeutics Emerges With $205M to Fill a Growing Gap in Gout Treatment
FirstWord Pharma
September 30, 2025Crystalys makes its debut with $205M to advance next-gen gout drug
Fierce Biotech
September 30, 2025James Mackay is tending to ‘unfinished business’ with new gout biotech and $205M fundraise
Reuters
September 30, 2025Crystalys Therapeutics launches with $205 million funding round for trials of gout drug
Endpoints News
September 30, 2025